Post-partum hemorrhage: New therapeutic options;L'emorragia critica post-partum: Nuove prospettive terapeutiche

Recenti Progressi in Medicina

Volumn 98, Issue 1, 2007, Pages 7-11

  Franchini, Massimo ^a,b  

^a Azienda Ospedaliera   (Italy)

^b Centro Emofilia   (Italy)

Author keywords

Hysterectomy; Post partum hemorrhage; Recombinant factor VII activated

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A;

DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; HUMAN; OFF LABEL DRUG USE; POSTPARTUM HEMORRHAGE; PROPHYLAXIS; REVIEW; UTERINE ATONY;

FACTOR VIIA; FEMALE; HUMANS; POSTPARTUM HEMORRHAGE; PREGNANCY; RECOMBINANT PROTEINS;

EID: 33847003025     PISSN: 00341193     EISSN: 00341193     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Bonnar J. Massive obstetric haemorrhage. Best Pract Res Clin Obstet Gynecol 2000; 14: 1-18.
2. Bouwmeester PW, Boite AC, van Geijn HP. Pharmacological and surgical therapy for primary postpartum hemorrhage. Curr Pharm Design 2005; 11: 759-73.
3. Dildy GA, III. Postpartum hemorrhage: new management options. Clin Obstet Gynecol 2002; 45: 330-44.
4. Sobieszczyk S, Breborowicz G. Management recommendations for postpartum hemorrhage. Archives Perinat Med 2004; 10: 1-4.
5. Macphail S, Talks K. Massive post-partum haemorrhage and management of disseminated intravascular coagulation. Curr Obst Gynaecol 2004; 14: 123-31.
6. Franchini M: Postpartum acquired factor VIII inhibitors. Am J Hematol 2006;
7. Franchini M, Zaffanello M, Veneri D. Recombinant factor VIIa. An update on its clinical use. Thromb Haemost 2005; 93: 1027-35.
8. Haya S, Casana P, Espinos C, et al. Hereditary factor VII deficiency in pregnancy: Cesarean treatment with recombinant FVIIa. Haemophilia 1998; 4: 292(abstract).
9. Muleo G, Santoro R, Iannaccaro PG, Papaleo P, Leo F. The use of recombinant activated factor VII in congenital and acquired factor VII deficiencies. Blood Coagul Fibrinolysis 1998; 9: 389-90.
10. Santagostino E, Gringeri A, Mannucci PM. Home treatment with recombinant activated factor VII in patients with factor VIII inhibitors: the advantages of early intervention. Br J Haematol 1999; 104: 22-6.
11. Jimenez-Yuste V, Villar A, Morado M, et al. Continuous infusion of recombinant activated factor VII during Caesarean section delivery in a patient with congenital factor VII deficiency. Haemophilia 2000; 6: 588-90.
12. Moscardo F, Perez F, de la Rubia J, et al. Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII. Br J Haematol 2001; 113: 174-6.
13. Brueckner-Sabine, Sedemund-Adib-Beate, Malik-Eduard, et al. Treatment of a post partum bleeding complication with recombinant factor VIIa. Blood 2001; 98: 80b (abstract).
14. Mazzucconi MG, Bizzoni L, Giorgi A, et al. Postpartum inhibitor to factor VIII: treatment with high-dose immunoglobulin and dexamethasone. Haemophilia 2001; 7: 422-7.
15. Monte S, Lyons G. Peripartum management of a patient with Glanzmann's thrombasthenia using thrombelastograph. Br J Anaesthesia 2002; 87: 734-8.
16. Breborowicz GH, Sobieszczyk S, Szymankiewicz M. Efficacy of recombinant activated factor VII (rFVIIa, NovoSeven®) in prenatal medicine. Arch Perinat Med 2002; 8: 21-7.
17. Zupancic SS, Sokolic V, Viskovic T, Sanjug J, Simic M, Kastelan M. Successful use of recombinant factor VIIa for massive bleeding after caesarean section due to HELLP syndrome. Acta Haematol 2002; 108: 162-3.
18. Sobieszczyk S, Breborowicz GH, Markwitz W, Mallinger S, Adamski D, Kruszynski Z. Effect of recombinant activated factor VII (RFVIIA; NovoSeven) in a patient in haemorrhagic shock after obstetrical hysterectomy. Ginekol Pol 2002; 73: 230-3.
19. Eskandari N, Feldman N, Greenspoon JS. Factor VII deficiency in pregnancy treated with recombinant factor Vila. Obstet Gynecol 2002; 99: 935-7.
20. Sokolic V, Bukovic D, Fures R, et al. Recombinant factor VIIa (rFVIIa) is effective at massive bleeding after cesarean section - a case report. Coll Antropol 2002; 26(suppl): 155-7.
21. Baudo F, Gaidano G, Carloni MT, et al. Recombinant activated factor VII (rFVIIa) for the treatment of bleeding secondary to acquired Factor VIII inhibitor. Blood 2002; 100: 3877 (abstract).
22. Bouwmeester FW, Jonkhoff AR, Verheijen RHM, van Geijn HP. Successful treatment of life-threatening postpartum hemorrhage with recombinant activated factor VII. Obstet Gynecol 2003; 101: 1174-6.
23. Kretzschmar M, Zahm DM, Remmler K, Pfeiffer L, Victor L, Schirmeister W. Pathophysiological and therapeutic aspects of amniotic fluid embolism (anaphylactoid syndrome of pregnancy): case report with lethal outcome and overview. Anaesthesist 2003; 52: 419-6.
24. Boyer-Neumann C, Dreyfus M, Wolf M, Veyradier A, Meyer D. Multi-therapeutic approach to manage delivery in an alloimmunized patient with type 3 von Willebrand disease. J Thromb Haemost 2003; 1: 190-2.
25. Dart BW, Cockerham WT, Torres C, Kipikasa JH, Maxwell RA. A novel use of recombinant factor VIIa in HELLP syndrome associated with spontaneous hepatic rupture and abdominal compartment syndrome. J Trauma 2004; 57: 171-4.
26. Boehlen F, Morales MA, Fontana P, Ricou B, Irion O, de Moerloose P. Prolonged treatment of massive postpartum haemorrhage with recombinant factor VIIa: case report and review of the literature. Br J Obstet Gynaecol 2004; 111: 284-7.
27. Segal S, Shemesh IY, Blumental R, et al. The use of recombinant factor VIIa in severe postpartum hemorrhage. Acta Obstet Gynecol Scand 2004; 83: 771-2.
28. Merchant S, Mathew P, Vanderjagt TJ, Howdieshell TR, Crookston KP. Recombinant factor VIIa in management of spontaneous subcapsular liver hematorna associated with pregnancy. Obstet Gynecol 2004; 103: 1055-8.
29. Kale A, Bayhan G, Yalinkaya A, Yayla M. The use of recombinant factor VIIa in a primigravida with Glanzmann's thrombasthenia during delivery. J Perinat Med 2004; 32: 456-8.
30. Lim Y, Loo CC, Chia V, Fun W. Recombinant factor VIIa after amniotic fluid embolism and disseminated intravascular coagulopathy. Int J Gynecol Obstet 2004; 87: 178-9.
31. Price G, Kaplan J, Skowronski G. Use of recombinant factor VIIa to treat life-threatening non-surgical bleeding in a post-partum patient. Br J Anaesth 2004; 93: 298-300.
32. Gidiri M, Noble W, Rafique Z, Patil K, Lindow SW. Caesarean section for placenta praevia complicated by postpartum haemorrhage managed successfully with recombinant activated human coagulation Factor VIIa. J Obstet Gynaecol 2004; 24: 925-6.
33. Ahonen J, Jokela R. Recombinant factor VIIa for life-threatening post-partum haemorrhage. Br J Anaesth 2005; 94: 592-5.
34. Shamsi TS, Hossain N, Soomro N, et al. Use of Recombinant factor VIIa for massive postpartum haemorrhage: Case series and review of literature. J Pak Med Assoc 2005; 55: 512-5.
35. Tanchev S, Platikanov V, Karadimov D. Administration of recombinant factor VIIa for the management of massive bleeding due to uterine atonia in the post-placental period. Acta Obstet Gynecol Scand 2005; 84: 402-3.
36. Holub Z, Feyereisl J, Kabelik L, Rittstein T. Successful treatment of severe post-partum bleeding after Caesarean section using recombinant activated factor VII. Ces Gynek 2005; 70: 144-8.
37. Hollnberger H, Gruber E, Seelbach GB. Major post-partum hemorrhage and treatment with recombinant factor VIIa. Anesth Analg 2005; 101: 1886-7.
38. Nowacka E, Krawczynska WR, Teliga CJ, et al. Recombinant factor VIIa for severe bleeding during Cesarean section for quadruplet pregnancy. Case report. Anest Intens Ter 2005; 37: 259-62.
39. Verre M, Bossio F, Mammone A, Piccirillo M, Tancioni F, Varano M. Use of recombinant activated factor VII in a case of severe postpartum haemorrhage. Minerva Ginecol 2006; 58: 81-4.
40. Palomino MA, Chaparro MJ, de Elvira MJ, Curiel EB. Recombinant activated factor VII in the management of massive obstetric bleeding. Blood Coagul Fibrinolysis 2006; 17: 226-7.